Sep 17, 2020 / 12:45PM GMT
David Reed Risinger - Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst
Great. So good morning, everyone, and thank you for joining the session with Perrigo. My name is Dave Risinger, and I cover both major and specialty pharmaceuticals at Morgan Stanley. And it's very much my pleasure to welcome Perrigo to participate today.
I do need to refer you to a disclaimer. This webcast is only for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. If you are a member of the press, please disconnect and reach out separately. Please reference www.morganstanley.com/disclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
I want to apologize for our late start. We will try to run it 5 minutes late to recapture some of the time. So thank you for your patience, everyone, in particular, Murray and Ray. So it's my pleasure to welcome Murray Kessler, President and CEO;
Perrigo Company PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers